Stockreport

MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance [Yahoo! Finance]

MaxCyte, Inc.  (MXCT) 
PDF enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced its fourth quarter and f [Read more]